AbCellera
expansion manufacturing the goal future plans for deepening the tech stack include a a a financial post receives million from the government of canada to discover solutions for covid and build a manufacturing facility for antibody drugs cell line development manufacturing facility for production of for clinical testing this facility which is partly funded by a grant by the government of canada will be the first in canada capable of going from a patient sample to manufacturing antibodies for clinical testing | AbCellera
Company
Deck Type
IPO
Sector
Industry
Deck date
December 2020
Slide
38 of 38
Related slides by other companies
Lordstown Motors
Results
May 2022
manufacturing facility and supply chain preparedness an | Lordstown Motors
Lion Electric
Investor Presentation
November 2023
existing manufacturing footprint in canada existing manufacturing footprint with a maximum capacity of vehicles per year lion electric | Lion Electric
BioNTech
Results
May 2020
update on covid program i a a a | BioNTech
BioNTech
Results
May 2020
manufacturing update clinical supply global pandemic and commercial supply capacities | BioNTech
Other recent decks by AbCellera
See all presentations (23 decks)
Investor Presentation
February 2024
Investor Conference
January 2024
Results
November 2023
Investor Presentation
November 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights